Santarus, Geron lead drug stocks north

Santarus Inc. leads drug stocks north as shares of the biotech group zoomed skyward on news that it has obtained the exclusive U.S. license to commercialize the diabetes drug Cycloset.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.